The AHS fellow, director of MedStar Georgetown Headache Center, and associate professor of neurology at MedStar Georgetown University Hospital spoke to what to expect from this year’s annual scientific meeting.
“We’re really getting to see where science has been in the last year when it comes to headache medicine, and focus in on some of the details of the research. I think that’s always important as a clinician.”
On June 13, 2020, the American Headache Society (AHS) will be kicking off its annual scientific meeting, though, like many other major medical meetings, it will be held virtually. With a need to shift rather rapidly to this format, it is easy to understand why a number of physicians, scientists, and the like would wonder what to anticipate from such a meeting.
To find out exactly what that community should expect to see and hear about, NeurologyLive reached out to Jessica Ailani, MD, FAHS, director, MedStar Georgetown Headache Center, and associate professor of neurology, MedStar Georgetown University Hospital. Ailani­, who is a member of the scientific committee for the meeting, offered her perspective on the science that is expected to be presented.
Notably, she spoke to how important these presentations ultimately end up being for those practicing headache medicine, saying that she is “always looking at where the scientists are right now because what they’re doing today is what’s going to come to my patients in 5 to 10 years from now.” These presentations, she said, will give attendees the chance to take a head-to-the-ground type approach to the ongoing science in headache.
For more AHS 2020 coverage, click here.